Research Notes

NIKE enters October with wholesale growth, weaker direct demand, and blurred margin comparisons as investors look for a more durable turnaround signal.

Vicor’s raised third-quarter outlook confirms an operating step-up, while royalty durability, product demand, and capacity returns remain unproven.

Aya Gold & Silver pairs stronger Zgounder cash generation with a Boumadine project that still must clear feasibility, funding, and execution tests.

Acuity enters October 1 with Lighting under pressure, Intelligent Spaces growing quickly, and the operating mix still awaiting confirmation from results.

Accenture enters October 1 with resilient margins and cash flow, while bookings and Consulting growth test whether demand can broaden across the business.

Celldex Therapeutics has replicated Phase 3 CSU efficacy, while longer-duration data, filing execution, and commercial proof remain unfinished.

Jabil enters September 30 with infrastructure growth, stronger cash conversion, and a working-capital test that can shape its fiscal 2027 outlook.

Micron Technology brings exceptional revenue, margin, and cash momentum to September 30, where HBM4 durability and cycle risk meet a high evidence bar.

Conagra Brands enters September 30 with weaker demand, improving cash discipline, and a test of whether its fiscal reset can hold the stated frame.

BlackBerry’s broader growth now faces a September 24 durability test across QNX, Secure Communications, retention, cash conversion, and guidance.